Journey Medical (DERM) Net Cash Flow (2020 - 2026)
Journey Medical's (DERM) quarterly Net Cash Flow came in at $3.1 million in Q1 2026, up 309.02% YoY from $765000.0 in Q1 2025, and up 464.69% on a QoQ basis from -$858000.0 in Q4 2025.
Journey Medical (DERM) Net Cash Flow (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Net Cash Flow data on file, last reported at $3.1 million in Q1 2026.
- Quarterly Net Cash Flow rose 309.02% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (down 48.81% YoY) and the FY2025 annual result came in at $3.8 million, up 153.06% from the prior year.
- Net Cash Flow improved to $3.1 million in Q1 2026, from -$858000.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $12.8 million in Q4 2024 to a low of -$9.1 million in Q2 2023.
- A 5-year average of -$403647.1 and a median of -$858000.0 in 2025 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 420.81% in 2025, down 435.86% in 2025.
- Tracing DERM's Net Cash Flow over 5 years: stood at -$2.9 million in 2022, then jumped by 193.14% to $2.7 million in 2023, then soared by 377.47% to $12.8 million in 2024, then tumbled by 106.68% to -$858000.0 in 2025, then jumped by 464.69% to $3.1 million in 2026.
- The last three Net Cash Flow figures came in at $3.1 million (Q1 2026), -$858000.0 (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Journey Medical | 212.53 Mn | 186.88 Mn | 12.37 Mn | -1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.58 Mn |
| Jun 30, 2026 | -1.58 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | -858,000.00 |
| Dec 31, 2025 | -858,000.00 |
| Sep 30, 2025 | 4.66 Mn |
| Sep 30, 2025 | 4.66 Mn |
| Jun 30, 2025 | -777,000.00 |
| Jun 30, 2025 | -777,000.00 |
| Mar 31, 2025 | 765,000.00 |
| Mar 31, 2025 | 765,000.00 |
| Dec 31, 2024 | 12.84 Mn |
| Dec 31, 2024 | 12.84 Mn |
| Sep 30, 2024 | -1.45 Mn |
| Sep 30, 2024 | -1.45 Mn |
| Jun 30, 2024 | -145,000.00 |
| Jun 30, 2024 | -145,000.00 |
| Mar 31, 2024 | -3.38 Mn |
| Mar 31, 2024 | -3.38 Mn |